MORE►
Colossal Foundation
The Karankawa Tribe of Texas named the first cloned "ghost wolf" pup Neka Kayda, meaning "Ghost Daughter," and recognized her as the tribe's totem animal—one of many milestones in the Foundation's inaugural Impact Report. [Photo: Courtesy of Colossal]
Dallas’ Colossal Foundation Joins IUCN in $4M ‘Race Against Time’ Effort to Prevent Extinction
by Sandra Engelland | Sep 17, 2026
The foundation and IUCN Species Survival Commission have launched a four-year partnership that will use Colossal Biosciences’ technology to improve tracking of endangered species, including overlooked fungi, plants, invertebrates, fishes and reptiles.
by Sandra Engelland |
Jul 7, 2026
By using a vaccine and gene editing, the partners aim to fight a lethal cancer that has reduced the wild population of Tasmanian devils by 80% since the 1990s.
MORE►
by Quincy Preston |
Apr 30, 2026
At a $10 billion valuation—and spinning out new ventures—Colossal names the bluebuck its sixth de-extinction target, extending its biotech platform into antelope conservation through a global BioVault effort.
MORE►
by Quincy Preston |
Dec 17, 2025
Dallas-based Colossal Biosciences’ nonprofit arm has doubled its funding to $100 million and released its first Impact Report as it puts technology to work from Yellowstone to the Texas Gulf Coast—and beyond.
MORE►
Ben Lamm at the Colossal Lab in Dallas. [Photo: Colossal Biosciences]
Dallas’ Colossal Biosciences Becomes Texas’ First Decacorn, Securing $10.2B Valuation With Series C Funding
by Quincy Preston | Jan 15, 2025
Best known for its moonshot mission to revive the woolly mammoth, Colossal Biosciences has secured $200 million in Series C funding led by TWG Global. The world's first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, Colossal Biosciences is working to restore Earth's lost biodiversity, "making science fiction into science fact."
MORE►
by Lance Murray |
Jan 14, 2025
The funding will support groundbreaking research into artificial womb technologies with the goal of protecting endangered species and advancing wildlife conservation efforts, the foundation said.
MORE►
by Lance Murray |
Dec 17, 2024
“Helping to stop the spread of chytrid is a necessity to ensure healthy ecosystems globally,” said Colossal Foundation Director Matt James. “This isn’t optional. We have to give frogs a fighting chance and ensure they remain a vital part of our planet’s biodiversity for generations to come."
MORE►
by Lance Murray |
Nov 21, 2024
“As bird species disappear, we lose key components of ecosystems, including pollinators, insectivores, and spreaders of seeds, with negative impacts for both human and planetary health," said Colossal co-founder and CEO Ben Lamm.
MORE►
